… of triple therapy versus dual bronchodilation. In particular, no studies have directly compared
single-inhaler triple therapy with single-inhaler dual bronchodilator therapy for reducing …

… Long-acting bronchodilators are the mainstay of therapy due to their proven efficacy. GOLD
guidelines recommend combining long-acting bronchodilators with differing mechanisms of …

… in the tiotropium 5 μg group than in the 2·5 μg group, and the small … bronchodilator reversibility
between the treatment groups. Indeed, an association between increased bronchodilator …

… Few data are available for the efficacy of “triple therapy” with two long-acting bronchodilators
and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD). We …

… and the lack of a run-in period meant that we did not select individuals who could manage
without inhaled bronchodilator therapy. Finally, the observed exacerbation rate was close to …

… was that the potent bronchodilator effect of a fixed-… bronchodilator therapy, particularly in
terms of prevention of COPD exacerbations. We also expected that a greater bronchodilator …

… hours after taking oral or inhaled bronchodilator therapy. Three measurements were taken
… Patients were also asked to record the number of inhalations of bronchodilator aerosol used …

… monotherapy, so comparisons with other active therapies can only … therapy, there remains
limited data available in less symptomatic patient subgroups with dual bronchodilator therapy. …

… Limited data are available for the efficacy of triple therapy with two long-acting bronchodilators
and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD). We …

… The study was a randomized, double-blind, 85-day, parallelgroup, eight-center … bronchodilator
agents to patients with COPD. 1 Beneficial effects of maintenance bronchodilator therapy …